Predicting stomach cancer risk in people with high-risk features
Part of Digestive system clinical trials.
This study uses endoscopy findings to predict if high-risk patients will develop stomach cancer or precancerous changes. It aims to improve follow-up care for people with signs of infection or stomach lining thinning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 45 years or older.
- You must have at least one risk factor for stomach cancer, such as living in a high-risk area, H. pylori infection, a history of certain stomach conditions, or having a close family member with stomach cancer.
- Your initial stomach scope must not show cancer or precancer, but it must show active H. pylori infection or a type of stomach lining thinning called atrophic gastritis.
- You cannot have had part or all of your stomach removed.
- You must not be taking blood thinners or have a bleeding disorder.
- You cannot be pregnant or breastfeeding.
- You must not have severe heart, lung, liver, or kidney disease, or another active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a condition called atrophic gastritis (thinning of the stomach lining) can help predict who is more likely to develop stomach cancer. It may help with early detection and prevention.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study follows people who carry a high-risk type of Helicobacter pylori (a stomach bacteria) to see if they develop gastric cancer. It aims to understand who is most at risk and how to monitor them over time.
This study looks at people with chronic atrophic gastritis to estimate who may be at higher risk of stomach cancer over time. It collects symptom and medical data, plus blood and tissue samples, to build prediction models that may improve future care.
This trial looks at adults with stomach lining changes—either atrophic gastritis or intestinal metaplasia—and studies how to predict who may be at risk for stomach cancer. It may help earlier identification and closer monitoring for people with these conditions.
Hear when a new Gastric Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.